Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : TATRADER GIZZARD STUDY--Stocks 12.00 or Less..... -- Ignore unavailable to you. Want to Upgrade?

To: TATRADER who wrote (26259)	12/6/2001 1:29:12 PM
From: wgh613	Read Replies (1) \| Respond to of 59879

NMTI from Briefing: 13:17 ET NMT Medical., Inc (NMTI) 7.21 +0.96 (+15.3): Announcement this morning of FDA pre-market approval of CardioSEAL has ignited a 16% move in the stock. Advance has occurred on turnover of 537K, or 7x avg. daily volume. The device, a cardiac septal repair implant, has been approved for patients with ventricular septal defects that are not candidates for surgical closure Manny T.